Ivermectin and Mebendazole in Cancer Treatment

It was the largest human, uh, observational study on

ivermectin, mebendazole, and cancer.

We had like two hundred cancer patients, and what we found was after

six months, eighty-four point four percent of them

reported to

have benefited in their cancer treatments.

About half, either their cancers disappeared, they had

no evidence of disease, or their tumors shrank.

And again, that is half of this entire cohort.

And then thirty-six percent reported their cancer stabilized.

It wasn't spreading anymore. And so that's very promising.

So if we see that in active cancer, we would suspect it would

prevent cancers because in the preclinical studies in the

rats and in the test tube, the ivermectin and mebendazole

have over fourteen distinct anti-cancer mechanisms.

So it attacks cancer across a variety of ways, not just a

single one, uh, like, say, uh, chemo, for example.